Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (SHE:301246)
China
· Delayed Price · Currency is CNY 25.89
+0.69 (2.74%)
At close: Apr 29, 2026
SHE:301246 Market Cap
SHE:301246 has a market cap or net worth of 10.27 billion as of April 29, 2026. Its market cap has increased by 88.68% in one year.
Market Cap
10.27B
Enterprise Value
9.20B
Revenue
1.94B
Ranking
n/a
PE Ratio
86.33
Stock Price
25.89
Market Cap Chart
Since March 20, 2023, SHE:301246's market cap has decreased from 16.78B to 10.27B, a decrease of -38.78%. That is a compound annual growth rate of -14.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 10.00B | 0.80% |
| Dec 31, 2025 | 9.92B | 84.22% |
| Dec 31, 2024 | 5.39B | -48.18% |
| Dec 29, 2023 | 10.39B | -38.07% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tianjin Chase Sun Pharmaceutical Co.,Ltd | 10.09B |
| Beijing Foyou Pharma CO.,LTD | 9.77B |
| Harbin Pharmaceutical Group | 9.24B |
| Yantai Dongcheng Pharmaceutical Group | 11.02B |
| PharmaBlock Sciences (Nanjing) | 9.02B |
| North China Pharmaceutical Company.Ltd | 9.01B |
| Shanghai Yizhong Pharmaceutical | 11.18B |
| Mayinglong Pharmaceutical Group | 11.19B |